AKR Corporindo Tbk PT
IDX:AKRA
AKR Corporindo Tbk PT
IDX:AKRA
Price:
1 130
IDR
-0.88%
Market Closed
Market Cap:
22.7T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
AKRA Alert
AKR Corporindo Tbk PT
1130
-10 (-0.88%)
| 52 Week Range |
1 120
1 850
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
AKR Corporindo Tbk PT
Balance Sheet
Balance Sheet Decomposition
AKR Corporindo Tbk PT
AKR Corporindo Tbk PT
| Current Assets | 18.1T |
| Cash & Short-Term Investments | 4.7T |
| Receivables | 7.7T |
| Other Current Assets | 5.7T |
| Non-Current Assets | 11.7T |
| Long-Term Investments | 2.4T |
| PP&E | 6.8T |
| Other Non-Current Assets | 2.5T |
| Current Liabilities | 11.6T |
| Accounts Payable | 8.7T |
| Accrued Liabilities | 641.7B |
| Other Current Liabilities | 2.3T |
| Non-Current Liabilities | 7.5T |
| Long-Term Debt | 3.8T |
| Other Non-Current Liabilities | 3.7T |
Balance Sheet
AKR Corporindo Tbk PT
AKR Corporindo Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
436 831
|
1 161 653
|
867 086
|
1 103 752
|
1 998 741
|
1 657 625
|
54 309
|
61 785
|
156 815
|
6 535 626
|
|
| Cash |
436 831
|
1 161 653
|
867 086
|
1 103 752
|
1 998 741
|
1 657 625
|
0
|
0
|
0
|
6 273 562
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
54 309
|
61 785
|
156 815
|
262 064
|
|
| Short-Term Investments |
459 760
|
128 156
|
499 857
|
781 514
|
172 342
|
203 156
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
4 485 421
|
3 152 752
|
2 694 401
|
2 943 047
|
4 647 430
|
4 521 176
|
2 673 114
|
4 622 657
|
6 030 180
|
6 467 129
|
|
| Accounts Receivables |
4 309 106
|
3 049 205
|
2 569 271
|
2 696 132
|
4 404 614
|
4 320 950
|
2 368 361
|
4 488 568
|
5 971 459
|
6 403 444
|
|
| Other Receivables |
176 315
|
103 548
|
125 130
|
246 915
|
242 816
|
200 225
|
304 753
|
134 089
|
58 721
|
63 685
|
|
| Inventory |
934 877
|
976 998
|
862 466
|
1 072 638
|
1 356 979
|
1 621 346
|
1 037 337
|
2 380 875
|
3 051 343
|
3 133 622
|
|
| Other Current Assets |
402 856
|
1 866 039
|
2 467 569
|
2 915 398
|
3 093 105
|
2 774 337
|
2 782 604
|
2 418 655
|
2 421 790
|
1 984 675
|
|
| Total Current Assets |
6 719 745
|
7 285 599
|
7 391 379
|
8 816 349
|
11 268 598
|
10 777 639
|
8 042 419
|
12 022 678
|
15 841 294
|
18 121 052
|
|
| PP&E Net |
4 390 207
|
4 469 498
|
4 561 738
|
4 214 694
|
4 921 528
|
5 325 172
|
5 591 500
|
5 547 019
|
5 582 890
|
6 084 249
|
|
| PP&E Gross |
4 390 207
|
4 469 498
|
4 561 738
|
4 214 694
|
4 921 528
|
5 325 172
|
5 591 500
|
5 547 019
|
5 582 890
|
6 084 249
|
|
| Accumulated Depreciation |
2 202 322
|
2 613 669
|
2 841 510
|
2 914 451
|
2 661 835
|
2 967 820
|
3 325 322
|
3 675 266
|
4 124 734
|
4 375 263
|
|
| Goodwill |
30 805
|
11 889
|
12 451
|
12 554
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
74 983
|
540 659
|
809 424
|
1 070 878
|
928 456
|
1 016 660
|
714 189
|
702 350
|
538 182
|
403 653
|
|
| Long-Term Investments |
447 315
|
429 397
|
460 328
|
414 784
|
418 163
|
1 556 199
|
1 531 465
|
2 364 084
|
2 366 255
|
2 329 123
|
|
| Other Long-Term Assets |
3 128 863
|
2 466 088
|
2 595 420
|
2 293 949
|
2 404 106
|
2 733 375
|
2 804 001
|
2 872 454
|
2 858 986
|
3 316 547
|
|
| Other Assets |
30 805
|
11 889
|
12 451
|
12 554
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
14 791 917
N/A
|
15 203 130
+3%
|
15 830 741
+4%
|
16 823 209
+6%
|
19 940 851
+19%
|
21 409 046
+7%
|
18 683 573
-13%
|
23 508 586
+26%
|
27 187 608
+16%
|
30 254 623
+11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 982 234
|
3 433 701
|
3 184 496
|
3 777 447
|
4 996 896
|
5 835 094
|
3 011 754
|
7 766 849
|
9 239 324
|
9 519 186
|
|
| Accrued Liabilities |
228 764
|
197 715
|
147 376
|
150 929
|
207 548
|
353 260
|
310 899
|
436 886
|
818 948
|
759 574
|
|
| Short-Term Debt |
1 238 797
|
663 606
|
831 714
|
271 490
|
1 312 060
|
1 681 876
|
881 530
|
121 702
|
1 574
|
5 000
|
|
| Current Portion of Long-Term Debt |
372 863
|
310 287
|
1 382 709
|
683 551
|
1 114 646
|
458 734
|
395 311
|
468 221
|
570 109
|
1 169 548
|
|
| Other Current Liabilities |
361 098
|
266 094
|
269 413
|
546 075
|
431 577
|
383 563
|
502 616
|
513 183
|
650 537
|
1 080 070
|
|
| Total Current Liabilities |
6 183 756
|
4 871 402
|
5 815 708
|
5 429 491
|
8 062 728
|
8 712 526
|
5 102 110
|
9 306 841
|
11 280 492
|
12 533 378
|
|
| Long-Term Debt |
2 514 764
|
2 910 577
|
1 823 544
|
2 217 875
|
1 803 070
|
2 469 493
|
2 839 586
|
2 467 603
|
2 444 880
|
3 454 218
|
|
| Deferred Income Tax |
47 069
|
37 323
|
12 262
|
18 073
|
18 582
|
5 075
|
6 780
|
8 764
|
11 395
|
18 384
|
|
| Minority Interest |
570 674
|
1 195 839
|
1 253 217
|
1 471 658
|
1 555 723
|
1 730 587
|
1 803 979
|
1 953 849
|
2 185 948
|
2 780 333
|
|
| Other Liabilities |
77 601
|
97 652
|
104 906
|
128 119
|
129 640
|
155 091
|
178 740
|
426 413
|
296 030
|
205 686
|
|
| Total Liabilities |
9 393 865
N/A
|
9 112 793
-3%
|
9 009 637
-1%
|
9 265 218
+3%
|
11 569 742
+25%
|
13 072 771
+13%
|
9 931 196
-24%
|
14 163 469
+43%
|
16 218 745
+15%
|
18 991 999
+17%
|
|
| Equity | |||||||||||
| Common Stock |
391 364
|
394 903
|
399 178
|
400 633
|
401 469
|
401 469
|
401 469
|
401 469
|
401 469
|
401 469
|
|
| Retained Earnings |
3 852 961
|
4 375 360
|
5 028 694
|
5 625 394
|
6 410 237
|
6 401 191
|
6 930 562
|
7 518 359
|
9 093 923
|
9 396 616
|
|
| Additional Paid In Capital |
770 412
|
927 743
|
1 135 196
|
1 236 067
|
1 287 163
|
1 287 163
|
1 287 163
|
1 287 163
|
1 287 163
|
1 287 163
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
118 072
|
118 072
|
118 072
|
118 072
|
|
| Other Equity |
383 315
|
392 330
|
258 036
|
295 897
|
272 238
|
246 451
|
251 255
|
256 197
|
304 379
|
295 448
|
|
| Total Equity |
5 398 053
N/A
|
6 090 336
+13%
|
6 821 104
+12%
|
7 557 991
+11%
|
8 371 108
+11%
|
8 336 275
0%
|
8 752 377
+5%
|
9 345 116
+7%
|
10 968 863
+17%
|
11 262 624
+3%
|
|
| Total Liabilities & Equity |
14 791 917
N/A
|
15 203 130
+3%
|
15 830 741
+4%
|
16 823 209
+6%
|
19 940 851
+19%
|
21 409 046
+7%
|
18 683 573
-13%
|
23 508 586
+26%
|
27 187 608
+16%
|
30 254 623
+11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3 940
|
3 949
|
19 959
|
20 032
|
20 073
|
20 073
|
19 737
|
19 737
|
19 737
|
19 737
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
